Market revenue in 2022 | USD 8.2 million |
Market revenue in 2030 | USD 18.8 million |
Growth rate | 10.9% (CAGR from 2022 to 2030) |
Largest segment | 13-24 weeks |
Fastest growing segment | 0-12 weeks |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | 0-12 weeks, 13-24 weeks, 25-36 weeks |
Key market players worldwide | CooperSurgical, Natera Inc, Eurofins Scientific SE, Illumina Inc, Centogene NV Ordinary Shares, MedGenome, Myriad Genetics Inc, Roche Holding AG, Qiagen NV, Labcorp Holdings Inc, Quest Diagnostics Inc, Biora Therapeutics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non invasive prenatal testing market will help companies and investors design strategic landscapes.
13-24 weeks was the largest segment with a revenue share of 52.44% in 2022. Horizon Databook has segmented the UAE non invasive prenatal testing market based on 0-12 weeks, 13-24 weeks, 25-36 weeks covering the revenue growth of each sub-segment from 2018 to 2030.
UAE healthcare authorities are working to ensure better healthcare outcomes for its citizens. In February 2018, the Dubai Health Authority introduced the Human Genome Project as a part of the Dubai 10X initiative. As per the initiative, sequencing and gene mapping for approximately 3 million residents and noncitizens of Dubai were expected to commence in the coming months.
In addition, the government of the UAE was hosting several medical and healthcare conferences to strengthen its healthcare network. For instance, in November 2022, it hosted Medlab Middle East, the largest laboratory exhibition in MENA. This exhibition was about emerging trends in testing kits.
Such initiatives by the government are likely to fuel the demand for clinical laboratories in the country. The Ministry of Health & Prevention (MOHAP) is a leading regulatory authority in the country. The authority is responsible for all clinical laboratory and clinical test regulations in the UAE.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE non invasive prenatal testing market , including forecasts for subscribers. This country databook contains high-level insights into UAE non invasive prenatal testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account